Back to 
Neuberger Berman Group LLC
Neuberger Berman Group LLC
DBTX
Showing 0 of 11 quarters
Position history for Neuberger Berman Group LLC's holdings in Decibel Therapeutics Inc
No. Neuberger Berman exited its DBTX (Decibel Therapeutics) position in Q3 2023. Its Q2 2023 13F listed 58,800 shares worth $226,380. Neuberger Berman already held DBTX in its Q1 2021 13F, the earliest on record, and held it in 10 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of DBTX: Citadel Advisors LLC, Alphabet Inc.